Civil Class Action Complaint Courts Documents Investment Listed Securities United Kingdom United States District Court for the District of Delaware USASeptember 8, 2020

Adam Franchi v. Spring Bank Pharmaceuticals, Inc. et al: Class Action Complaint

Class Action Complaint alleging violations of the Securities Exchange Act in Adam Franchi v. Spring Bank Pharmaceuticals, Inc., of Massachusetts, described as “a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleotide platform” whose shares are listed on NASDAQ; David Arkowitz, Todd Brady, Timothy Clackson, Martin Driscoll, Kurt M. Eichler, Pamela Klein, Scott Smith, and F-star Therpaeutics Limited, of England, at the U. S. District Court for the District of Delaware.


    • 12
    September 08, 2020
    Spring Bank Pharmaceuticals, Inc., David Arkowitz, Todd Brady, Timothy Clackson, Martin Driscoll, Kurt M. Eichler, Pamela Klein, Scott Smith, F-star Therpaeutics Limited
    Gina Serra, Rigrodsky Law
    Xx Xx Xx
    Investment, Listed Securities
    Adam Franchi

    Topics

    Investment Listed Securities USA United Kingdom

    Keywords

    Adam Franchi David Arkowitz F-star Therpaeutics Limited Kurt M. Eichler Martin Driscoll
    Pamela Klein Scott Smith Spring Bank Pharmaceuticals, Inc. Timothy Clackson Todd Brady
    [ 5 more... ] [ top 5 ]